The Fly | GSK

GlaxoSmithKline

· GSK

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Yesterday

GSK announces commencement of tender offer to acquire Nuvalent

Yesterday, 9:59 AM

Over a week ago

GSK, Spero Therapeutics announce FDA approval of Utebzi

Jun 17, 11:11 AM

CMS proposes to lock in lower prices in Medicare drug price negotiation program

Jun 15, 12:08 PM

GSK announces momelotinib granted ODD from U.S. FDA, EMA

Jun 12, 7:01 AM

Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls

+17

Jun 10, 9:42 AM

What You Missed On Wall Street On Tuesday

+27

Jun 9, 4:18 PM

Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent

+26

Jun 9, 11:56 AM

Nuvalent downgraded to Hold from Buy at Stifel

Jun 9, 10:22 AM

Video: Nuvalent jumps after GSK's $10.6B takeover deal

Jun 9, 9:07 AM

Morning Movers: Nuvalent surges following $10.6B deal to be acquired

Jun 9, 8:53 AM

GSK agrees to acquire Nuvalent for $124 per share

Jun 9, 8:04 AM

GSK in talks to buy Nuvalent for $9B-$10B, FT says

Jun 8, 10:28 PM

Acting FDA head vows to block political interference, Endpoint News says

+23

Jun 4, 2:11 PM

FDA issues draft guidance to help accelerated cell, gene therapies for patients

+24

Jun 2, 9:40 AM

GSK's ViiV Healthcare launches PrEP Wisdom campaign

Jun 1, 8:15 AM

Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint

May 28, 5:15 AM

GSK to present new data from portfolio, pipeline at ASCO Annual Meeting

May 26, 9:32 AM

Trump Trade: Trump announces expansion of TrumpRx.gov

+13

May 19, 9:51 AM

What You Missed On Wall Street On Monday

+34

May 18, 4:11 PM

Trump to announce 'dramatic expansion' of TrumpRx offerings, CNBC says

May 18, 11:32 AM

GSK announces Japan's MHLW expanded eligible population for Arexvy

May 18, 6:40 AM

Davis to become acting director of CDER after Hoeg exit, Bloomberg says

+10

May 15, 3:38 PM

AnaptysBio price target raised by $5 at Leerink, here's why

May 15, 10:51 AM

Trump Trade: Nvidia CEO joins China trip, Diamantas tapped as acting FDA chief

+12

May 13, 10:06 AM

What You Missed On Wall Street On Tuesday

+47

May 12, 4:11 PM

Robust R&D Pipeline: A strong and focused research and development engine drives future growth and innovation, particularly in immunology, HIV, and infectious diseases.

Specialized Portfolio Focus: A strategic concentration on high-growth areas like specialty medicines and vaccines provides deep expertise and market leadership.

Global Market Penetration: An extensive worldwide presence allows for broad distribution and access to diverse patient populations and markets.

Clinical Development Failure: The failure of investigational drugs in clinical trials can lead to significant write-offs and delayed revenue streams.

Patent Expiry & Generic Competition: The loss of patent exclusivity on key products exposes them to generic competition, causing substantial revenue erosion.

Regulatory Scrutiny & Approval Delays: Strict regulatory environments can lead to delays in drug approvals, additional data requirements, or market restrictions.

Charts

Robust R&D Pipeline: A strong and focused research and development engine drives future growth and innovation, particularly in immunology, HIV, and infectious diseases.

Specialized Portfolio Focus: A strategic concentration on high-growth areas like specialty medicines and vaccines provides deep expertise and market leadership.

Global Market Penetration: An extensive worldwide presence allows for broad distribution and access to diverse patient populations and markets.

Clinical Development Failure: The failure of investigational drugs in clinical trials can lead to significant write-offs and delayed revenue streams.

Patent Expiry & Generic Competition: The loss of patent exclusivity on key products exposes them to generic competition, causing substantial revenue erosion.

Regulatory Scrutiny & Approval Delays: Strict regulatory environments can lead to delays in drug approvals, additional data requirements, or market restrictions.

Yesterday

GSK announces commencement of tender offer to acquire Nuvalent

Yesterday, 9:59 AM

Over a week ago

GSK, Spero Therapeutics announce FDA approval of Utebzi

Jun 17, 11:11 AM

CMS proposes to lock in lower prices in Medicare drug price negotiation program

Jun 15, 12:08 PM

GSK announces momelotinib granted ODD from U.S. FDA, EMA

Jun 12, 7:01 AM

Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls

+17

Jun 10, 9:42 AM

What You Missed On Wall Street On Tuesday

+27

Jun 9, 4:18 PM

Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent

+26

Jun 9, 11:56 AM

Nuvalent downgraded to Hold from Buy at Stifel

Jun 9, 10:22 AM

Video: Nuvalent jumps after GSK's $10.6B takeover deal

Jun 9, 9:07 AM

Morning Movers: Nuvalent surges following $10.6B deal to be acquired

Jun 9, 8:53 AM

GSK agrees to acquire Nuvalent for $124 per share

Jun 9, 8:04 AM

GSK in talks to buy Nuvalent for $9B-$10B, FT says

Jun 8, 10:28 PM

Acting FDA head vows to block political interference, Endpoint News says

+23

Jun 4, 2:11 PM

FDA issues draft guidance to help accelerated cell, gene therapies for patients

+24

Jun 2, 9:40 AM

GSK's ViiV Healthcare launches PrEP Wisdom campaign

Jun 1, 8:15 AM

Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint

May 28, 5:15 AM

GSK to present new data from portfolio, pipeline at ASCO Annual Meeting

May 26, 9:32 AM

Trump Trade: Trump announces expansion of TrumpRx.gov

+13

May 19, 9:51 AM

What You Missed On Wall Street On Monday

+34

May 18, 4:11 PM

Trump to announce 'dramatic expansion' of TrumpRx offerings, CNBC says

May 18, 11:32 AM

GSK announces Japan's MHLW expanded eligible population for Arexvy

May 18, 6:40 AM

Davis to become acting director of CDER after Hoeg exit, Bloomberg says

+10

May 15, 3:38 PM

AnaptysBio price target raised by $5 at Leerink, here's why

May 15, 10:51 AM

Trump Trade: Nvidia CEO joins China trip, Diamantas tapped as acting FDA chief

+12

May 13, 10:06 AM

What You Missed On Wall Street On Tuesday

+47

May 12, 4:11 PM

Company News

GlaxoSmithKline

· GSK

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Company News

Charts

Charts

GlaxoSmithKline

· GSK

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation